Ways clinical pharmacists can add value in intermediate care settings
Patients in intermediate care are “low risk” with regard to medicines issues so they have little need for a clinical pharmacy service, right? Ateam of pharmacists from Harrow wish to argue otherwise
Mrs AB is an 85-year-old woman who has been admitted to hospital after a fall. The clinicians have determined that there is no serious underlying cause, so she no longer requires acute hospital care. However, an appropriate package of care is not yet available that would allow her to return home safely.
Mr TP lives at home but is bed-bound. He is developing a pressure sore. With prompt intervention, the sore can be managed but a hospital admission is not warranted at this stage. For both him and Mrs AB, intermediate care is ideal.
The full text article is available to read as a PDF (top right)
Hanisha Amin is a rotational pharmacist, Krupa Dave is acute admissions and older people pharmacist, and Nina Barnett is consultant pharmacist for older people, all at North West London Hospitals Trust.
Citation: Clinical Pharmacist URI: 11090853
Recommended from Pharmaceutical Press